Form 4: Climb Bio Director Converts Restricted Stock Units to Common Shares
Insider Transaction Report
Climb Bio, Inc. Director Stephen Basil Thomas converted 25,094 restricted stock units into common stock, increasing his direct beneficial ownership to 204,282 shares.
Summary
- Stephen Basil Thomas, a Director of Climb Bio, Inc. (CLYM), reported a change in beneficial ownership.
- On June 27, 2025, Thomas acquired 25,094 shares of Climb Bio, Inc. Common Stock.
- This acquisition resulted from the conversion of 25,094 Restricted Stock Units (RSUs).
- Following this transaction, Thomas directly beneficially owns 204,282 shares of Common Stock.
- The RSUs were granted on June 27, 2024, with vesting occurring in tranches: 50% on January 1, 2025, 25% on March 27, 2025, and the final 25% on June 27, 2025, contingent on continued service.
Sentiment
Score: 7
Explanation: The transaction reflects a routine vesting and conversion of Restricted Stock Units (RSUs) for a director, resulting in an increase in their direct beneficial ownership. This indicates continued alignment of the director's interests with the company's performance.
Positives
- Director Stephen Basil Thomas increased his direct beneficial ownership in Climb Bio, Inc. by 25,094 shares, demonstrating continued alignment with shareholder interests.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction related to equity compensation, which is common across all industries for publicly traded companies. It does not provide information relevant to broader industry trends or competitive landscape.
Related Party Transactions
- The conversion of Restricted Stock Units (RSUs) into common stock for Director Stephen Basil Thomas is part of his compensation package.
- Stephen Thomas granted a Power of Attorney to Chandra Adams, Aoife Brennan, and Cindy Driscoll, employees of Climb Bio, Inc., to prepare and file Section 16 reports on his behalf.
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed positively as it aligns management interests with shareholder value.
- Employees: The RSU vesting demonstrates a standard compensation mechanism for key personnel.
Key Dates
| Date | Description |
|---|---|
| 06/27/2024 | Restricted Stock Units (RSUs) were granted to Stephen Basil Thomas. |
| 01/01/2025 | 50% of the granted Restricted Stock Units (RSUs) vested. |
| 03/27/2025 | An additional 25% of the granted Restricted Stock Units (RSUs) vested. |
| 06/27/2025 | The remaining 25% of the Restricted Stock Units (RSUs) vested and were converted into common stock; this is also the transaction date for the reported acquisition. |
| 07/01/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
Keywords
Climb Bio, CLYM, Form 4, insider transaction, stock ownership, restricted stock units, RSU conversion, director, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.